Orlistat in the treatment of obesity

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.1, Iss.4, 2000-05, pp. : 841-847

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Currently Available Drugs for the Treatment of Obesity: Sibutramine and Orlistat

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 1, 2007-01 ,pp. : 3-10

Bentham Science Publishers

Access to resources Recommend Favorite

The use of orlistat in the treatment of obesity, dyslipidaemia and Type 2 diabetes

By Nelson Robert H Miles John M

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 14, 2005-11 ,pp. : 2483-2491

Informa Healthcare

Access to resources Recommend Favorite

Orlistat weighs in against obesity in adolescents

Inpharma, Vol. 1, Iss. 1450, 2004-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Orlistat: A Review of its Use in the Management of Obesity

By Henness Sheridan Perry Caroline M.

Drugs, Vol. 66, Iss. 12, 2006-01 ,pp. : 1625-1656

Adis International

Access to resources Recommend Favorite

Orlistat: its current status as an anti-obesity drug

By Ballinger A. Peikin S.R.

European Journal of Pharmacology, Vol. 440, Iss. 2, 2002-04 ,pp. : 109-117

Elsevier

Access to resources Recommend Favorite